Vimarsana
Biggest News Aggregation in the World

Page 36 - Nasdaq First News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq First. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq First Today - Breaking & Trending Today

Eco Wave Power Announces Nasdaq First North Delisting and Last Day of Trading as Part of U.S. Focus (2) - Vimarsana News

Eco Wave Power Announces Nasdaq First North Delisting and Last Day of Trading as Part of U.S. Focus (2)

STOCKHOLM, May 30, 2022 /PRNewswire/ -- Eco Wave Power Global AB (publ) (Nasdaq: WAVE, Nasdaq First North:...

EWPG Holding AB (publ): Eco Wave Power Announces Nasdaq First North Delisting and Last Day of Trading as Part of U.S. Focus - Vimarsana News

EWPG Holding AB (publ): Eco Wave Power Announces Nasdaq First North Delisting and Last Day of Trading as Part of U.S. Focus

ADSs Will Continue to Trade on the Nasdaq Capital Market in the U.S. STOCKHOLM, May 30, 2022 /PRNewswire/ -- Eco Wave Power Global AB (publ) (Nasdaq: WAVE, Nasdaq First North: ECOWVE) ("Eco

Eco Wave Power Announces Nasdaq First North Delisting and Last Day of Trading as Part of U.S. Focus (1) - Vimarsana News

Eco Wave Power Announces Nasdaq First North Delisting and Last Day of Trading as Part of U.S. Focus (1)

STOCKHOLM, May 30, 2022 /PRNewswire/ -- Eco Wave Power Global AB (publ) (Nasdaq: WAVE, Nasdaq First North:...

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Presentation of Biomarker Analysis at ASCO - Vimarsana News

Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Presentation of Biomarker Analysis at ASCO

Investegate announcements from Faron Pharma. Oy, Presentation of Biomarker Analysis at ASCO

Presentation of Biomarker Analysis at ASCO - Press Release - Vimarsana News

Presentation of Biomarker Analysis at ASCO - Press Release

Faron Pharmaceuticals Ltd("Faron or Company")Faron Announces Presentation of Biomarker Analysis at 2022 ASCO Annual Meeting Showing Promising Clinical